James Dorchak, MD
Obstetrics & Gynecology · Columbus, GANPI 1609972868
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $25,800 of the $32,793 with a category attached, or 78.7%. 28 manufacturers reported payments, led by AbbVie at 47.9% of the total. Reporting peaked in 2019 at $26,941 and has fallen 99.7% since, to $92 in 2025. Among obstetrics & gynecology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 161 payments — averaging $203.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$16K
- Duchesnay USA Incorporated$15K
- Medtronic$506
- Radius Health, Inc.$280
- Pfizer$193
- Caldera Medical, Inc$142
- plus $904 from 22 others
What the payments were for
- Speaking & faculty fees$25,80079%
- Travel & lodging$3,44110%
- Food & beverage$3,47311%
- Education$780%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $15,694 |
| Duchesnay USA Incorporated | 30 | $15,075 |
| Medtronic(2 entities) | 15 | $506 |
| Radius Health, Inc. | 13 | $280 |
| Pfizer | 12 | $193 |
| Caldera Medical, Inc | 2 | $142 |
| Astellas Pharma US Inc | 5 | $84 |
| Hologic Sales And Service, LLC | 4 | $80 |
| Exeltis, USA Inc. | 4 | $76 |
| Evofem Biosciences, Inc. | 4 | $76 |
| Bayer | 4 | $67 |
| Globus Medical | 1 | $67 |
| Zyla Life Sciences, Inc. | 3 | $53 |
| Baxter Healthcare | 2 | $39 |
| Axonics, Inc. | 2 | $39 |
| Therapeuticsmd, Inc. | 3 | $39 |
| Boston Scientific | 2 | $38 |
| Roche Diagnostics Corporation | 2 | $38 |
| Johnson & Johnson | 1 | $35 |
| Mylan Pharmaceuticals Inc. | 2 | $31 |
| Lupin Inc. | 2 | $26 |
| Avion Pharmaceuticals | 2 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Coloplast | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Conmed Corporation | 1 | $14 |
| Myovant Sciences Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$32,793 in reported general payments places this provider in the 95th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 14 | $10,509 |
| Estradiol | 49 | $1,660 |
| Fluconazole | 11 | $51 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $84 | $10,50914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Other obstetrics & gynecology in Columbus
- Serena TidwellColumbus$16K
- Michael DempseyColumbus$8K
- Edmund KimLawrenceville$628K
- Jacquelin WaltersDuluth$147K
- Nicole SparksJohns Creek$121K
- Lethenia BakerThomaston$111K
- Renee AllenAtlanta$74K
- Matthew RalstenFayetteville$64K
- Murray FreedmanAugusta$48K
- Tosha Rogers-JonesAtlanta$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.